Oppenheimer raised the firm’s price target on Acadia Pharmaceuticals (ACAD) to $19 from $17 and keeps a Perform rating on…
Tag: Oppenheimer
BofA, Oppenheimer latest on Wall St to slash S&P 500’s annual target
(Reuters) – BofA Global Research and Oppenheimer Asset Management on Monday became the latest Wall Street research firms to cut…